222
Participants
Start Date
September 19, 2022
Primary Completion Date
November 30, 2024
Study Completion Date
December 31, 2025
RMC-6291
Oral tablet once or twice a day
Taipei Tzu Chi Hospital, New Taipei City
Southside Cancer Care Centre, Sydney
Seoul National University Hospital, Seoul
Austin Health, Olivia Newton-John Cancer Research & Wellness Centre, Heidelberg
Peninsula & South Eastern Haematology and Oncology Group, Frankston
South West Health Care, Warrnambool
Severance Hospital, Seoul
MSK Cancer Center, New York
Columbia University Irving Medical Center, New York
Azienda Ospedaliero-Universitaria San Luigi Gonzaga, Orbassano
National Taiwan University Hospital, Taipei
Siriraj Hospital, Bangkok Noi
MSB General Hospital, Belgrade
Clinical hospital center Bezanijska Kosa, Belgrade
Roswell Park Comprehensive Cancer Center, Buffalo
Ajou University Hospital, Suwon
Istituto Europeo Oncologico, Milan
S.C. Oncologia Falck, Dipartimento Ematologia ed Oncologia Niguarda Cancer Center, Milan
American Oncology Partners of Maryland, Bethesda
Institute for pulmonary diseases Sremska Kamenica, Kamenitz
Next Oncology Virginia, Fairfax
Fondazione IRCCS Policlinico San Matteo, Pavia
Clínica Universidad de Navarra, Madrid
MD Anderson Cancer Center, Madrid
Hospital Universitario Fundación Jiménez Díaz, Madrid
Hospital Universitario Quirónsalud, Pozuelo de Alarcón
Clinica Universidad de Navarra, Pamplona
CHU Bordeaux Hospital Saint-Andre, Bordeaux
University of Miami School of Medicine Sylvester Comprehensive Cancer Center, Miami
Moffitt Cancer Center, Tampa
Centro Ricerche Cliniche di Verona s.r.l., Verona
Tennessee Oncology, Nashville
Khon Kaen University, Khon Kaen
Hospital Universitario Virgen del Rocío, Seville
CHU Nantes, Nantes
ICO, Angers
Klinika onkologie a radioterapie, Fakultni Nemocnice Hradec Kralove, Hradec Králové
Hospital Universitario Miguel Servet, Zaragoza
Chiang Mai University, Chiang Mai
Centre Oscar Lambret, Lille
University Malaya Medical Centre, Kuala Lumpur
Centre Jean Perrin, Clermont-Ferrand
ICANS, Strasbourg
Centre Léon Bérard, Lyon
National Cheng Kung University Hospital, Tainan City
Highlands Oncology Group, Springdale
Onkologicka klinika, Fakultni Nemocnice Olomouc, Olomouc
Next Oncology, San Antonio
START, San Antonio
Istituto Nazionale Tumori Fondazione G. Pascale, Napoli
E-DA hospital, Kaohsiung City
UC Irvine Cancer Center, Orange
Sarawak General Hospital, Kuching
UCSF, San Francisco
UC Davis Cancer Center, Sacramento
National Cancer centre Singapore, Singapore
Dana-Farber Cancer Institute, Boston
NH Hospital a.s., Hořovice
Instytut MSF Sp zoo, Lodz
Med - Polonia Sp. z o. o., Poznan
Narodowy Instytut Onkologii, Warsaw
Korea University Hospital, Seoul
NEXT Oncology IOB Hospital Quirónsalud, Barcelona
ICO Hospitalet, Barcelona
Revolution Medicines, Inc.
INDUSTRY